Aclarion, Inc. Files Definitive Proxy Statement

TL;DR

Aclarion (ACRN) filed its DEF 14A proxy statement - shareholders vote soon.

AI Summary

Aclarion, Inc. filed a Definitive Proxy Statement (DEF 14A) on February 3, 2025, for its fiscal year ending December 31, 2024. The filing, which does not require a fee, provides information to shareholders regarding company matters. Aclarion, Inc. was formerly known as Nocimed, Inc. until a name change on February 26, 2015.

Why It Matters

This filing is important for shareholders as it outlines key information and proposals that will be voted on at the company's annual meeting, impacting corporate governance and future strategy.

Risk Assessment

Risk Level: low — This is a routine regulatory filing (DEF 14A) and does not contain new financial performance data or significant strategic announcements.

Key Numbers

• 1231 — Fiscal Year End (Indicates the end of the company's financial reporting year.)

Key Players & Entities

• Aclarion, Inc. (company) — Registrant
• Nocimed, Inc. (company) — Former company name
• February 3, 2025 (date) — Filing date
• February 26, 2015 (date) — Date of name change
• 80021 (location) — ZIP code

FAQ

Key Financial Figures

• $0.00001 — ce of shares of common stock, par value $0.00001 per share (the “common stock&rdqu

Filing Documents

• aclarion_def14a.htm (DEF 14A) — 173KB
• 0001683168-25-000634.txt ( ) — 174KB

SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT

SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT 14 OTHER MATTERS 15 HOUSEHOLDING 15 2023 ANNUAL REPORT 15 i QUESTIONS AND ANSWERS ABOUT THIS PROXY STATEMENT AND VOTING What is a proxy? A proxy is the legal designation of another person to vote the stock you own. That other person is called a proxy. If you designate someone as your proxy in a written document, that document is also called a proxy or a proxy card. By completing, signing and returning the accompanying proxy card, you are designating Brent Ness, Chief Executive Officer, and John Lorbiecki, Chief Financial Officer, as your proxies for the Special Meeting and you are authorizing Mr. Ness and Mr. Lorbiecki to vote your shares at the Special Meeting as you have instructed on the proxy card. This way, your shares will be voted whether or not you attend the Special Meeting. Even if you plan to attend the Special Meeting, we urge you to vote in one of the ways described below so that your vote will be counted even if you are unable or decide not to attend the Special Meeting. What is a proxy statement? A proxy statement is a document that we are required by regulations of the U.S. Securities and Exchange Commission, or “SEC,” to give you when we ask you to sign a proxy card designating Mr. Ness and Mr. Lorbiecki as proxies to vote on your behalf. Why did you send me this proxy statement? We sent you this proxy statement and the enclosed proxy card because our board of directors is soliciting your proxy to vote at the Special Meeting and any adjournment and postponement thereof. This proxy statement summarizes information related to your vote at the Special Meeting. All stockholders who find it convenient to do so are cordially invited to attend the Special Meeting at the Company’s offices in person. However, you do not need to attend the meeting to vote your shares. Instead, you may simply complete, sign and return the proxy card or vote over the Interne

View Full Filing

View this DEF 14A filing on SEC EDGAR